Astria Therapeutics
ATXS
ATXS
28 hedge funds and large institutions have $33.1M invested in Astria Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5.5% more ownership
Funds ownership: 0.56% → 6.06% (+5.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
28
Holding in Top 10
1
Calls
$8.91M
Puts
–
Top Buyers
| 1 | +$9.08M | |
| 2 | +$1.17M | |
| 3 | +$875K | |
| 4 |
Renaissance Technologies
New York
|
+$700K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$590K |
Top Sellers
| 1 | -$497K | |
| 2 | -$182K | |
| 3 | -$147K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$17.4K |